Sleep Apnea Devices Global Market - Forecast to 2026

Sleep Apnea Devices Global Market - Forecast to 2026

Sleep apnea is a serious disorder that occurs when breathing is interrupted during sleep, this happens, when the upper airway becomes repeatedly blocked and preventing the brain and lungs from getting enough oxygen, resulting in heavy snoring and choking. Patients are affected by different types of sleep apnea, such as obstructive sleep apnea (OSA) caused by the blockage of the airway, when the muscle in the back of the throat collapses during sleep, central sleep apnea (CSA), caused when the brain fails to send the signal to the muscle to breathe, due to instability in the respiratory control center and complex sleep apnea syndrome a mixture of OSA and CSA, that central sleep apnea may emerge during titration of CPAP in patients with obstructive sleep apnea. Sleep apnea may cause due to physical structure or certain medical conditions such as obesity, large tonsils, endocrine disorders, neuromuscular disorders, certain genetic syndrome and premature birth.

The Sleep apnea devices global market is expected to grow at high single digit CAGR from 2019 to 2026 to reach $8,173.8 million by 2026. The increase in the rate of sleep apnea population, increasing lifestyle changes that causing poor sleep patterns elevated rates of stress, obesity and cardiovascular disease and increasing funding and investment in patient monitoring are driving the market growth. However, the alternative therapies of sleep apnea, stringent regulatory requirements for product approvals and non-compliances of patients with PAP devices are restraining the market growth.

The Sleep apnea devices market segmented based on products, application, end-users and geography. The product market is segmented into diagnostic devices and treatment devices. According to IQ4I research, treatment devices accounted for the largest revenue in 2019 and expected to grow at high single digit CAGR from 2019 to 2026. The diagnostic devices segment is expected to grow at a mid-single digit CAGR from 2019 to 2026 due to increasing diagnosis rate of sleep apnea and increasing connectivity of rural areas.

The sleep apnea diagnostic devices market is further classified into in-lab sleep test and home sleep test. Among these, the in-lab sleep test accounted for the largest revenue in 2019 and the market is expected to grow at a mid-single digit CAGR from 2019 to 2026. Based on products, in – lab sleep test is further segmented into attended polysomnography (PSG), Respiratory polygraph and pulse oximeter. Among them, attended polysomnography segment held the largest revenue in 2019 of the market and the market is expected to grow at a high single digit CAGR from 2019 to 2026. Increasing incidence of obstructive sleep apnea, increasing demand for gold standard polysomnography devices are the factors driving the market growth. The home sleep test is further segmented into unattended polysomnography, Actigraphy and others, among these; unattended polysomnography segment accounted for the largest revenue in 2019 and the market is expected to grow at mid-single digit CAGR of from 2019 to 2026.

The sleep apnea treatment devices market is segmented into PAP devices, oral appliances, phrenic nerve stimulators, hypoglossal nerve stimulator and others. Among them, the PAP devices segment commanded the largest revenue in 2019 and the market is expected to grow at high single digit CAGR from 2019 to 2026. Increasing the incidence of sleep apnea disorder and increasing the use of PAP devices are the factors driving the market. The hypoglossal nerve stimulator is expected to grow at high teen CAGR from 2019 to 2026. PAP devices are further segmented into CPAP, APAP, BiPAP, ASV and accessories, among these, Accessories accounted for the largest revenue in 2019 and expected to grow at mid-single digit CAGR from 2019 to 2026, APAP devices segment is expected to grow at double digit CAGR from 2019 to 2026. An oral appliance segment is further segmented into Mandibular repositioning devices (MRD) and Tongue retaining devices (TRD), among these, MRD accounted for the largest revenue in 2019 and the market is expected to grow at mid-single digit CAGR from 2019 to 2026, due to increased use wearable devices. Accessories are further segmented into full face masks, nasal masks, nasal pillow masks and others, among these, the full face masks segmented is accounted for the largest revenue in 2019 and the market is expected to grow at double digit CAGR from 2019 to 2026.

The sleep apnea application market is segmented into obstructive sleep apnea (OSA), central sleep apnea (CSA) and complex sleep apnea syndrome (ComSAS). Among these, OSA accounted for the largest revenue in 2019 and the market is expected to grow at high single digit CAGR from 2019 to 2026.

The Sleep apnea devices global market based on end-user is segmented into hospitals, sleep centers, home healthcare and others. Among these, the sleep centers segment accounted for the largest revenue in 2019 and the market is expected to grow at high single digit from 2019 to 2026. The homecare market is expected to be the fastest-growing segment with high single digit CAGR from 2019 to 2026 due to the improvement and acceptance of home care devices has increased.

The Sleep apnea devices global market based on geography is segmented into North America, Europe, Asia – Pacific and Rest of the World, among these, North America accounted for the largest revenue of $2,365.1 million in 2019 and the market is expected to grow at a CAGR of high single digit from 2019 to 2026. Increasing awareness about the diseases complications in developed countries, high investments in healthcare infrastructures and demand for quality services are propelling the market growth. Asia – Pacific is expected to grow at a double digit CAGR from 2019 to 2026 due to increasing awareness about the health in emerging countries.

Major players in Sleep apnea devices global market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Fisher and Paykel Healthcare Corporation Ltd., (New Zealand), Apex Medical Corporation (Taiwan), Nihon Kohden Corporation (Japan) Natus Medical Inc.. (U.S.), Inspire Medical Inc. (U.S.), Drive Medical (Drive DeVilbiss Healthcare) (U.S.), and SomnoMed (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
North America
U.S.
Rest of North America
Europe
Germany
U.K.
France
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of APAC
Rest of the World (RoW)
Brazil
Rest of Latin America
Middle East and Others


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 The increasing rate of sleep apnea population
3.3.1.2 Increasing lifestyle changes that causing poor sleep patterns elevated rates of stress, obesity and cardiovascular disease
3.3.1.3 Favorable reimbursement policies
3.3.1.4 Technological advancements
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Alternative therapies of sleep apnea
3.3.2.2 Non-compliances of patients with pap devices
3.3.2.3 Lack of awareness about sleep apnea disorder
3.3.2.4 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.2 THE U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 INDIA
3.4.6 CHINA
3.4.7 JAPAN
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 INTRODUCTION
3.5.2 ARTIFICIAL INTELLIGENCE IN SLEEP APNEA DIAGNOSIS AND TREATMENT
3.5.3 MAGNAP TREATMENT FOR SLEEP APNEA
3.5.4 SMART PAP DEVICES
3.5.5 3D IMAGING THE NEW TREATMENT TECHNIQUES FOR OBSTRUCTIVE SLEEP APNEA
3.5.6 WEARABLE PATCH DEVICES TO DETECT SLEEP APNEA
3.5.7 SLEEP TELEMEDICINE IN DIAGNOSIS AND TREATMENT OF SLEEP APNEA
3.5.8 REMOTE MONITORING IN SLEEP APNEA MANAGEMENT AND PAP ADHERENCE
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 COMPETITIVE RIVALRY
3.6.4 BARGAINING POWER OF SUPPLIERS
3.6.5 BARGAINING POWER OF BUYERS
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8.1 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS
3.8.2 POLYSOMNOGRAPHY MARKET SHARE ANALYSIS
3.8.3 CPAP DEVICES MARKET SHARE ANALYSIS
3.8.4 APAP DEVICES MARKET SHARE ANALYSIS
3.8.5 BPAP MARKET SHARE ANALYSIS
3.9 CLINICAL TRIALS
3.10 SLEEP APNEA PRODUCT APPROVALS AND NEW PRODUCT LAUNCH
3.11 SLEEP APNEA DEVICES-DEALS
3.12 FUNDING SCENARIO
3.13 REIMBURSEMENT SCENARIO
3.14 SLEEP APNEA DEVICES UNITS SOLD, INSTALLED BASE AND MARKET PENETRATION
4 SLEEP APNEA DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 SLEEP APNEA DIAGNOSTIC DEVICES
4.2.1 IN-LAB SLEEP TEST
4.2.1.1 Attended polysomnography
4.2.1.2 Respiratory polygraph
4.2.1.3 Pulse oximeter
4.2.2 HOME SLEEP TEST
4.2.2.1 Unattended polysomnography
4.2.2.2 Actigraphy
4.2.2.3 Others
4.3 SLEEP APNEA TREATMENT DEVICES
4.3.1 POSITIVE AIRWAY PRESSURE DEVICES (PAP) AND ACCESSORIES
4.3.1.1 Continuous PAP Devices (CPAP)
4.3.1.2 Automatic Pap (APAP) Devices
4.3.1.3 Bi-Level Pap (BPAP) Devices
4.3.1.4 Adaptive Servo-Ventilator (ASV)
4.3.1.5 Accessories
4.3.1.5.1 Full face mask
4.3.1.5.2 Nasal masks
4.3.1.5.3 Nasal pillow masks
4.3.1.5.4 Other masks
4.3.2 ORAL APPLIANCES
4.3.3 MANDIBULAR REPOSITIONING DEVICE
4.3.4 TONGUE RETAINING DEVICES
4.3.5 PHRENIC NERVE STIMULATION (PNS)
4.3.6 HYPOGLOSSAL NERVE STIMULATION (HGNS)
4.3.7 OTHER SLEEP THERAPEUTIC DEVICES
5 SLEEP APNEA DEVICES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 OBSTRUCTIVE SLEEP APNEA (OSA)
5.3 CENTRAL SLEEP APNEA (CSA)
5.4 COMPLEX SLEEP APNEA
6 SLEEP APNEA DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 SLEEP CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS
7 SLEEP APNEA DEVICES MARKET BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 REST OF EUROPE
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATAM
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCH
8.3 APPROVALS
8.4 AGREEMENTS
8.5 ACQUISITION
8.6 OTHERS
9 MAJOR COMPANIES
9.1 APEX MEDICAL CORPORATION
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 DRIVE MEDICAL (DRIVE DEVILBISS HEALTHCARE).
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 INSPIRE MEDICAL SYSTEMS INC.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 KONINKLIJKE PHILIPS N.V.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 NATUS MEDICAL INCORPORATED.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 NIHON KOHDEN CORPORATION.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 RESMED INC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 SOMNOMED
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 VYAIRE MEDICAL, INC
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 3 DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 4 IN-LAB SLEEP TEST GLOBAL MARKET REVENUE, BY PRODUCT,
TABLE 5 ATTENDED POLYSOMNOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 6 RESPIRATORY POLYGRAPH GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 HOME SLEEP TEST GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 9 HOME SLEEP TEST GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 10 UNATTENDED POLYSOMNOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 11 ACTIGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 12 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 13 TREATMENT DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 14 PAP DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 15 PAP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 16 CPAP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 17 APAP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 18 BIPAP DEVCES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 19 ADAPTIVE SERVO-VENTILATOR (ASV) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 20 ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 21 ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 FULL FACE MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 23 NASAL MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 24 NASAL PILLOW MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 25 OTHER MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 26 ORAL APPLIANCES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 27 ORAL APPLIANCES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 28 MANDIBULAR REPOSITIONING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 29 TONGUE RETAINING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 30 PHRENIC NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 31 HYPOGLOSSAL NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 32 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 33 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY APLLICATION, (2018-2026) ($MN)
TABLE 34 OBSTRUCTIVE SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 35 CENTRAL SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 36 COMPLEX SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 37 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 38 HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 SLEEP CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION,
TABLE 41 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 42 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 43 NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 44 NORTH AMERICA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 45 NORTH AMERICA IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 46 NORTH AMERICA HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 47 NORTH AMERICA TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 48 NORTH AMERICA PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 49 NORTH AMERICA ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 50 NORTH AMERICA ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 51 NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 52 NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 53 NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 54 EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 55 EUROPE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 56 EUROPE IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 57 EUROPE HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 58 EUROPE TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 59 EUROPE PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 60 EUROPE ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 61 EUROPE ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 62 EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 63 EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 64 EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 65 APAC SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 66 APAC DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 67 APAC IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 68 APAC HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 69 APAC TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 70 APAC PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 71 APAC ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 72 APAC ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 73 APAC SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 74 APAC SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 75 APAC SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 76 ROW SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 77 ROW DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 78 ROW IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 79 ROW HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 80 ROW TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 81 ROW PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 82 ROW ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 83 ROW ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 84 ROW SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 85 ROW SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 86 ROW SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 87 NEW PRODUCT LAUNCH (2018-2019)
TABLE 88 APPROVALS (2018-2019)
TABLE 89 AGREEMENTS (2018-2019)
TABLE 90 ACQUISITION (2018-2019)
TABLE 91 OTHERS (2018-2019)
TABLE 92 APEX MEDICAL CORPORATION TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 93 FISHER AND PAYKEL TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
TABLE 94 FISHER AND PAYKEL TOTAL REVENUE, BY PRODUCTS, (2017-2019) (Q2) ($MN)
TABLE 95 FISHER AND PAYKEL TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 96 INSPIRE MEDICAL SYSTEMS INC.: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 97 INSPIRE MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY GEOGRAPHY(2017-2019) ($MN)
TABLE 98 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES,(2017-2019) ($MN)
TABLE 99 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 100 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 101 NATUS MEDICAL INCORPORATED: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 102 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 103 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY NEURO SEGMENT (2017-2019)($MN)
TABLE 104 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY REGION (2017-2019)($MN)
TABLE 105 NIHON KOHDEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q3) ($MN)
TABLE 106 NIHON KOHDEN: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 107 NIHON KOHDEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
TABLE 108 RESMED INC.: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) (Q2) ($MN)
TABLE 109 RESMED INC.: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) (Q2) ($MN)
TABLE 110 RESMED INC.: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) (Q2) ($MN)
LIST OF FIGURES
FIGURE 1 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION
(2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: SLEEP APNEA DEVICES GLOBAL MARKET
FIGURE 3 SLEEP APNEA DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 SLEEP APNEA DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 SLEEP APNEA DEVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 SLEEP APNEA DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 SLEEP APNEA DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 SLEEP APNEA DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 POLYSOMNOGRAPHY MARKET SHARE ANALYSIS BY MAJOR PLAYERS,
2019 (%)
FIGURE 12 CPAP DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 13 APAP DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 14 BPAP MARKET SHARE, BY KEY PLAYERS, 2019 (%)
FIGURE 15 GLOBAL PAP DEVICES PENETRATION, (2019)
FIGURE 16 GLOBAL ORAL APPLIANCES PENETRATION, (2019)
FIGURE 17 SLEEP APNEA DEVICES GLOBAL MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 18 DIAGNOSTIC DEVICES GLOBAL MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 19 IN-LAB SLEEP TEST GLOBAL MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 20 HOME SLEEP TEST GLOBAL MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 21 TREATMENT DEVICES GLOBAL MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 22 PAP DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 23 ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 24 ORAL APPLIANCES GLOBAL MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 25 SLEEP APNEA DEVICES GLOBAL MARKET SHARE, BY APPLICATION
(2019 V/S 2026) (%)
FIGURE 26 SLEEP APNEA DEVICES GLOBAL MARKET SHARE, BY END-USERS
(2019 V/S 2026) (%)
FIGURE 27 SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION
(2018-2026) ($MN), CAGR (%)
FIGURE 28 SLEEP APNEA DEVICES GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2019) (%) ($MN)
FIGURE 29 NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 30 NORTH AMERICA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT (2018 V/S 2026) (%)
FIGURE 31 NORTH AMERICA IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 32 NORTH AMERICA HOME SLEEP TEST MARKET SHARE, BY PRODUCT,
(2019 V/S 2026) (%)
FIGURE 33 NORTH AMERICA TREATMENT DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 34 NORTH AMERICA PAP DEVICE AND ACCESSORIES MARKET SHARE,
BY PRODUCT (2019 V/S 2026) (%)
FIGURE 35 NORTH AMERICA ACCESSORIES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 36 NORTH AMERICA ORAL APPLIANCES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 37 NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
FIGURE 38 NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 39 NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 40 NORTH AMERICA PAP MARKET PENETRATION, (2019)
FIGURE 41 NORTH AMERICA ORAL APPLIANCES PENETRATION, (2019)
FIGURE 42 U.S. SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 43 U.S. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 44 U.S. SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 45 U.S. SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 46 U.S. PAP MARKET PENETRATION, (2019)
FIGURE 47 U.S. ORAL APPLIANCES PENETRATION, (2019)
FIGURE 48 REST OF N.A. SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 49 REST OF N.A. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
FIGURE 50 REST OF N.A SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 51 REST OF N.A SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 52 CANADA PAP MARKET PENETRATION, (2019)
FIGURE 53 CANADA ORAL APPLIANCES PENETRATION, (2019)
FIGURE 54 MEXICO PAP MARKET PENETRATION, (2019)
FIGURE 55 MEXICO ORAL APPLIANCES PENETRATION, (2019)
FIGURE 56 EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 57 EUROPE DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 58 EUROPE IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 59 EUROPE HOME SLEEP TEST MARKET SHARE, BY PRODUCT,
(2019 V/S 2026) (%)
FIGURE 60 EUROPE TREATMENT DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 61 EUROPE PAP DEVICE MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 62 EUROPE ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 63 EUROPE ORAL APPLIANCES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 64 EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION
(2019 V/S 2026) (%)
FIGURE 65 EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY END-USER
(2019 V/S 2026) (%)
FIGURE 66 EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY
(2019 V/S 2026) (%)
FIGURE 67 EUROPE PAP MARKET PENETRATION, (2019)
FIGURE 68 EUROPE ORAL APPLIANCES PENETRATION, (2019)
FIGURE 69 GERMANY SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 70 GERMANY TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 71 GERMANY SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 72 GERMANY SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 73 GERMANY PAP MARKET PENETRATION, (2019)
FIGURE 74 GERMANY ORAL APPLIANCES PENETRATION, (2019)
FIGURE 75 U.K SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 76 U.K. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 77 U.K. SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 78 U.K. SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 79 U.K. PAP MARKET PENETRATION, (2019)
FIGURE 80 U.K. ORAL APPLIANCES PENETRATION, (2019)
FIGURE 81 FRANCE SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 82 FRANCE TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 83 FRANCE SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 84 FRANCE SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 85 FRANCE PAP MARKET PENETRATION, (2019)
FIGURE 86 FRANCE ORAL APPLIANCES PENETRATION, (2019)
FIGURE 87 REST OF E.U. SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 88 REST OF E.U. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
FIGURE 89 REST OF E.U. SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 90 REST OF E.U. SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 91 REST OF E.U. PAP MARKET PENETRATION, (2019)
FIGURE 92 REST OF E.U. ORAL APPLIANCES PENETRATION, (2019)
FIGURE 93 APAC SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 94 APAC DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 95 APAC IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 96 APAC HOME SLEEP TEST MARKET SHARE, BY PRODUCT,
(2019 V/S 2026) (%)
FIGURE 97 APAC TREATMENT DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 98 APAC PAP DEVICE AND ACCESSORIES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 99 APAC ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 100 APAC ORAL APPLIANCES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 101 APAC SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION
(2019 V/S 2026) (%)
FIGURE 102 APAC SLEEP APNEA DEVICES MARKET SHARE, BY END-USER
(2019 V/S 2026) (%)
FIGURE 103 APAC SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY
(2019 V/S 2026) (%)
FIGURE 104 APAC PAP MARKET PENETRATION, (2019)
FIGURE 105 APAC ORAL APPLIANCES PENETRATION, (2019)
FIGURE 106 JAPAN SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 107 JAPAN TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 108 JAPAN SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 109 JAPAN SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 110 JAPAN PAP MARKET PENETRATION, (2019)
FIGURE 111 JAPAM ORAL APPLIANCES PENETRATION, (2019)
FIGURE 112 CHINA SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 113 CHINA TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 114 CHINA SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 115 CHINA SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 116 CHINA PAP MARKET PENETRATION, (2019)
FIGURE 117 CHINA ORAL APPLIANCES PENETRATION, (2019)
FIGURE 118 INDIA SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 119 INDIA TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 120 INDIA SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 121 INDIA SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 122 INDIA PAP MARKET PENETRATION, (2019)
FIGURE 123 INDIA ORAL APPLIANCES PENETRATION, (2019)
FIGURE 124 REST OF APAC SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
FIGURE 125 REST OF APAC TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
FIGURE 126 REST OF APAC SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 127 REST OF APAC SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 128 REST OF APAC PAP MARKET PENETRATION, (2019)
FIGURE 129 REST OF APAC ORAL APPLIANCES PENETRATION, (2019)
FIGURE 130 ROW SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 131 ROW DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 132 ROW IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 133 ROW HOME SLEEP TEST MARKET SHARE, BY PRODUCT,
(2019 V/S 2026) (%)
FIGURE 134 ROW TREATMENT DEVICES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 135 ROW PAP DEVICE MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 136 ROW ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 137 ROW ORAL APPLIANCES MARKET SHARE, BY PRODUCT
(2019 V/S 2026) (%)
FIGURE 138 ROW SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION
(2019 V/S 2026) (%)
FIGURE 139 ROW SLEEP APNEA DEVICES MARKET SHARE, BY END-USER
(2019 V/S 2026) (%)
FIGURE 140 ROW SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY
(2019 V/S 2026) (%)
FIGURE 141 ROW PAP MARKET PENETRATION, (2019)
FIGURE 142 ROW ORAL APPLIANCES PENETRATION, (2019)
FIGURE 143 BRAZIL SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT,
(2019 V/S 2026) ($MN)
FIGURE 144 BRAZIL TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS,
(2019 V/S 2026) ($MN)
FIGURE 145 BRAZIL SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION
(2019 V/S 2026) ($MN)
FIGURE 146 BRAZIL SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER
(2019 V/S 2026) ($MN)
FIGURE 147 BRAZIL PAP MARKET PENETRATION, (2019)
FIGURE 148 BRAZIL ORAL APPLIANCES PENETRATION, (2019)
FIGURE 149 REST OF LATAM SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
FIGURE 150 REST OF LATAM TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
FIGURE 151 REST OF LATAM SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 152 REST OF LATAM SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
FIGURE 153 REST OF LATAM PAP MARKET PENETRATION, (2019)
FIGURE 154 REST OF LATAM ORAL APPLIANCES PENETRATION, (2019)
FIGURE 155 MIDDLE EAST AND OTHERS SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE,
BY PRODUCT, (2019 V/S 2026) ($MN)
FIGURE 156 MIDDLE EAST AND OTHERS TREATMENT DEVICES MARKET REVENUE,
BY PRODUCTS, (2019 V/S 2026) ($MN)
FIGURE 157 MIDDLE EAST AND OTHERS SLEEP APNEA DEVICES MARKET REVENUE,
BY APPLICATION (2019 V/S 2026) ($MN)
FIGURE 158 MIDDLE EAST AND OTHERS SLEEP APNEA DEVICES MARKET REVENUE,
BY END-USER (2019 V/S 2026) ($MN)
FIGURE 159 MIDDLE EAST AND OTHERS PAP MARKET PENETRATION, (2019)
FIGURE 160 MIDDLE EAST AND OTHERS ORAL APPLIANCES PENETRATION, (2019)
FIGURE 161 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 162 SWOT: APEX MEDICAL CORPORATION
FIGURE 163 SWOT: DRIVE MEDICAL (DRIVE DEVILBISS HEALTHCARE).
FIGURE 164 SWOT: FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
FIGURE 165 SWOT: INSPIRE MEDICAL SYSTEMS INC.
FIGURE 166 SWOT: KONINKLIJKE PHILIPS N.V.
FIGURE 167 SWOT: NATUS MEDICAL CORPORATION.
FIGURE 168 SWOT: NIHON KOHDEN

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook